ClinicalTrials.gov Scraper: Recruiting Trial Sites & Sponsors
Pricing
from $3.00 / 1,000 trial sites
ClinicalTrials.gov Scraper: Recruiting Trial Sites & Sponsors
Recruiting clinical trials from the ClinicalTrials.gov API v2, one row per recruiting site: sponsor, phase, condition, intervention, facility and city/state, newest updates first. Filter by condition, sponsor, phase, country, state and site status. Published contacts optional.
Pricing
from $3.00 / 1,000 trial sites
Rating
0.0
(0)
Developer
Groundplane Labs
Maintained by CommunityActor stats
0
Bookmarked
2
Total users
1
Monthly active users
a day ago
Last modified
Categories
Features
Share
ClinicalTrials.gov Recruiting Trial Sites & Sponsors (API v2)
Extract recruiting clinical studies from the official ClinicalTrials.gov REST API v2 (https://clinicaltrials.gov/api/v2/studies), including lead sponsor details, clinical phases, conditions, interventions, target enrollment and the participating trial sites. Optionally (off by default) it also returns the study contacts published on ClinicalTrials.gov for each study and site.
Supports two output modes:
- Site-row mode (
flattenSites: true, default): one row per matching clinical trial site (siteFacility,siteCity,siteState,siteCountry, and site-level contacts whenincludeSiteContactsis on), with study and sponsor metadata repeated on each row. - Study-row mode (
flattenSites: false): one row per study (nctId) with all matching trial locations nested undersites.
Who it's for
- CROs, patient recruitment vendors, eClinical / CTMS / EDC providers & specialty labs identifying active Industry-sponsored Phase 2 and Phase 3 studies and their participating clinical trial sites
- Biopharma business development & medical affairs teams tracking competing pipelines, sponsor classes (
INDUSTRY,NIH,FED,OTHER,OTHER_GOV,NETWORK,AMBIG,INDIV), and investigating facilities by therapeutic area and state - Clinical trial site networks &SMO teams monitoring newly updated recruiting trials across specific US states or countries
Input
All filters are optional. Default input pulls up to 200 US trial site rows from RECRUITING and NOT_YET_RECRUITING Industry-sponsored Phase 2 and Phase 3 clinical trials, most recently updated first. Only sites that are themselves recruiting or not yet recruiting are included, at most 20 sites per trial, and contact fields are off.
{"conditionOrDisease": "Non-Small Cell Lung Cancer","interventionOrTreatment": "","sponsorName": "","overallStatuses": ["RECRUITING", "NOT_YET_RECRUITING"],"sponsorClass": "INDUSTRY","phases": ["PHASE2", "PHASE3"],"updatedSinceDate": "2026-09-01","flattenSites": true,"siteCountries": ["United States"],"siteStates": ["CA", "TX", "NY"],"siteStatuses": ["RECRUITING", "NOT_YET_RECRUITING"],"maxSitesPerTrial": 20,"includeSiteContacts": false,"maxItems": 200}
| Field | Type | Default | Description |
|---|---|---|---|
conditionOrDisease | string | "" (all) | Condition or disease search (query.cond). |
interventionOrTreatment | string | "" (all) | Drug, biological, device, or procedure query (query.intr). |
sponsorName | string | "" (all) | Lead sponsor or collaborator query (query.spons). |
overallStatuses | array | ["RECRUITING", "NOT_YET_RECRUITING"] | Recruitment statuses (filter.overallStatus). |
sponsorClass | string | "INDUSTRY" | INDUSTRY, NIH, FED, OTHER, OTHER_GOV, NETWORK, AMBIG, INDIV, or ALL. |
phases | array | ["PHASE2", "PHASE3"] | EARLY_PHASE1, PHASE1, PHASE2, PHASE3, PHASE4, NA. |
updatedSinceDate | string (YYYY-MM-DD) | "" | Minimum LastUpdatePostDate (AREA[LastUpdatePostDate]RANGE[<date>,MAX]). |
flattenSites | boolean | true | Emit one row per matching study site (true) or one row per study (false). |
siteCountries | array of strings | ["United States"] | Filter trial locations by country name. |
siteStates | array of strings | [] (all) | Filter trial locations by state/province (accepts both 2-letter US codes like "TX" and full names like "Texas"). |
siteStatuses | array | ["RECRUITING", "NOT_YET_RECRUITING"] | Keep only sites with these site-level recruitment statuses. Empty list = all sites. |
maxSitesPerTrial | integer | 20 | Maximum sites returned per trial, so one large trial doesn't fill the whole result. 0 = no cap. |
includeSiteContacts | boolean | false | Also return central and site contact names, emails and phones as published on ClinicalTrials.gov. Read the compliance section first. |
maxItems | integer | 200 | Maximum number of output rows. |
Output
| Field | Type | Description |
|---|---|---|
nctId | string | ClinicalTrials.gov NCT identifier |
briefTitle | string | null | Study brief title |
overallStatus | string | null | Recruitment status (RECRUITING, NOT_YET_RECRUITING, etc.) |
phases | array of strings | Clinical phases (PHASE2, PHASE3, etc.) |
conditions | array of strings | Conditions or diseases studied |
interventions | array of strings | Intervention names |
enrollmentTarget | integer | null | Target or actual participant enrollment count |
startDate | string | null | Study start date |
lastUpdatePostDate | string | null | Last update posted date |
leadSponsorName | string | null | Lead sponsor organization name |
leadSponsorClass | string | null | Lead sponsor class (INDUSTRY, NIH, FED, OTHER, OTHER_GOV, NETWORK, AMBIG, INDIV) |
centralContactName | string | null | Central published study contact name (as listed on ClinicalTrials.gov). Only with includeSiteContacts |
centralContactEmail | string | null | Central published study contact email (as listed on ClinicalTrials.gov). Only with includeSiteContacts |
centralContactPhone | string | null | Central published study contact phone (as listed on ClinicalTrials.gov). Only with includeSiteContacts |
overallOfficial | string | null | Primary overall study official (Name (Role) - Affiliation). Only filled when includeSiteContacts is on; otherwise null. |
overallOfficialRole | string | null | Role of the primary overall official (e.g. PRINCIPAL_INVESTIGATOR). Always included. |
overallOfficialAffiliation | string | null | Affiliation of the primary overall official. Always included. |
siteFacility | string | null | Trial site facility name |
siteStatus | string | null | Site-specific recruitment status |
siteCity | string | null | Trial site city |
siteState | string | null | Trial site state or province |
siteZip | string | null | Trial site postal/ZIP code |
siteCountry | string | null | Trial site country |
siteContactName | string | null | Site-level published study contact name (as listed on ClinicalTrials.gov). Only with includeSiteContacts |
siteContactRole | string | null | Site-level published study contact role. Only with includeSiteContacts |
siteContactEmail | string | null | Site-level published study contact email (as listed on ClinicalTrials.gov). Only with includeSiteContacts |
siteContactPhone | string | null | Site-level published study contact phone (as listed on ClinicalTrials.gov). Only with includeSiteContacts |
sites | array | null | Array of matching sites when flattenSites is false (null in site-row mode) |
studyUrl | string | Direct URL: https://clinicaltrials.gov/study/<nctId> |
Dates: ClinicalTrials.gov publishes startDate at mixed precision. A full date ships as YYYY-MM-DD; a study that only publishes a month or a year ships as YYYY-MM or YYYY. lastUpdatePostDate is always a full date.
Sample output row
{"nctId": "NCT07221669","briefTitle": "A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)","overallStatus": "RECRUITING","phases": ["PHASE3"],"conditions": ["Muscular Atrophy, Spinal"],"interventions": ["Salanersen"],"enrollmentTarget": 30,"startDate": "2026-04-28","lastUpdatePostDate": "2026-10-23","leadSponsorName": "Biogen","leadSponsorClass": "INDUSTRY","centralContactName": null,"centralContactEmail": null,"centralContactPhone": null,"overallOfficial": null,"overallOfficialRole": "STUDY_DIRECTOR","overallOfficialAffiliation": "Example Biotherapeutics","studyUrl": "https://clinicaltrials.gov/study/NCT07221669","siteFacility": "Ann and Robert H Lurie Childrens Hospital of Chicago","siteStatus": "RECRUITING","siteCity": "Chicago","siteState": "Illinois","siteZip": "60611","siteCountry": "United States","siteContactName": null,"siteContactRole": null,"siteContactEmail": null,"siteContactPhone": null,"sites": null}
How pricing works
Pay per result. You only pay for rows returned.
Data source and terms
Source: ClinicalTrials.gov, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health, via its REST API v2 (https://clinicaltrials.gov/api/v2/studies). ClinicalTrials.gov updates daily on federal business days; each row's lastUpdatePostDate is the date ClinicalTrials.gov last posted an update for that study. Use of the data is subject to the ClinicalTrials.gov Terms and Conditions.
Modified/derived data notice: this Actor does not change study content, but it reshapes it: it selects a subset of fields, flattens each study into one row per site (repeating study fields), keeps only the first central and site contact, filters sites by country/state/site status, caps sites per trial, and removes contact fields unless includeSiteContacts is on. For the authoritative, current record always check studyUrl. This Actor is not affiliated with or endorsed by NLM, NIH or ClinicalTrials.gov.
Compliance: contact data
- No unsolicited marketing. ClinicalTrials.gov's terms say email addresses from its database must not be used for marketing or promotional purposes. Contacts are published so patients and referring clinicians can ask about a study.
- CAN-SPAM and TCPA apply to any commercial email, call or text you send in the US. Don't autodial or text without the required consent.
- GDPR / UK GDPR and other privacy laws apply to contacts at non-US sites (and many named US contacts are personal data). You need a lawful basis to process them.
- Keep
includeSiteContactsoff unless you need contacts for a permitted purpose.
Labeled canary input
{"conditionOrDisease": "Non-Small Cell Lung Cancer","siteStates": ["CA", "TX", "NY"],"updatedSinceDate": "2026-09-01","maxItems": 5}
A healthy canary run succeeds with a status starting Complete: 5 of ... and every row a US site in California, Texas or New York.
Run status
Every run ends with a status you can trust:
Complete:means all matched rows were delivered (up tomaxItems), with the studies scanned, the query total, and the source's newestlastUpdatePostDatestated.PARTIAL:lists the concrete source reasons (studies skipped by row validation, field values shipped null on format drift, or a source whose newest update is more than 14 days old) and appends the Issues-tab line. A run stopped only by the max charge limit is PARTIAL without that line.- Zero matches is a success:
Complete: 0 rows matched your filters, with the scanned count stated.
Troubleshooting
- Zero rows. Widen the filters: set
sponsorClasstoALL, add phases or statuses, or clear the condition, intervention, sponsor, country and state filters. A study only produces site rows for sites that pass the country, state and site-status filters, so a study can match the study-level filters and still produce no site rows. - PARTIAL: source may be stale. ClinicalTrials.gov updates daily on federal business days. If the newest
lastUpdatePostDatein the result is more than 14 days old, the run says so instead of presenting old data as fresh. - PARTIAL: studies skipped or values shipped null. The source record shape drifted for part of the result. The counts are in the status message; the rows that did ship passed validation.
- Stopped early: max charge limit. Raise the run's max total charge to get more rows.
Limits and FAQ
- Why are
siteContactNameorsiteContactEmailsometimesnull? Large industry sponsors often publish a centralized trial hotline/email (centralContactName,centralContactEmail,centralContactPhone) while listing only facility names and phone numbers at individual sites, whereas academic and mid-size biotech trials more frequently list individual site coordinator names and emails. WithincludeSiteContactson, both central and site-level contacts are included on every row. - Can I pass 2-letter state codes like
"CA"insiteStates? Yes. ClinicalTrials.gov stores full state names ("California") on US locations, and this Actor automatically matches both 2-letter US postal codes ("CA") and full state names ("California").
Changelog
-
v0.2 - Deep-audit hardening: core-module sentinel and per-row validation (skipped studies counted, run fails if over 20 percent fail), value-format drift ships null and is counted instead of shipping bad values verbatim, Complete/PARTIAL status contract with scanned/matched counts and source freshness (14 day line), zero matches now succeeds, fleet retry standard (6 tries, jittered backoff, Retry-After honored), full sponsor-class domain (OTHER_GOV, NETWORK, AMBIG, INDIV now selectable), strict integer and boolean inputs.
-
v0.1.2 - Contacts are off by default (
includeSiteContacts). NewsiteStatusesfilter (default recruiting / not yet recruiting) andmaxSitesPerTrialcap (default 20). Added source attribution and a modified-data notice. -
v0.1.1 - Results are sorted by most recently updated study first.
-
v0.1 - Initial release supporting ClinicalTrials.gov API v2 Essie advanced filters, automatic US state code/name matching, and site/study row modes.